Genetically predicted HDL-C levels significantly improved post-stroke recovery (β = -0.138, p = 0.032), while LDL-C showed no causal effect (p = 0.097).
Do genetically determined HDL-C and LDL-C levels improve post-stroke recovery in patients with ischemic stroke?
Genetically determined higher HDL-C levels, but not LDL-C levels, are associated with improved post-stroke recovery, suggesting a potential role for HDL-C in neuroplasticity.
Absolute Event Rate: 0% vs 0%
Background: It is well-established that elevated low-density lipoprotein cholesterol (LDL-C) levels increase stroke risk, while elevated high-density lipoprotein cholesterol (HDL-C) levels are protective. While treatment of elevated LDL-C levels is a standard of care for secondary stroke prevention, it is unknown if elevated LDL-C and HDL-C levels impact recovery after ischemic stroke. Methods: We conducted a two-sample Mendelian Randomization (MR) study to assess the causal effects of genetically determined LDL-C and HDL-C on post-stroke recovery, as measured by longitudinal NIH Stroke Scale (NIHSS) scores. We utilized the trans-ancestral summary statistics from the Global Lipids Genetic Consortium (GLGC) (n=1,654,960) for instrument selection, the Vitamin Intervention for Stroke Prevention trial (n=1,200) for outcome associations, and the Stress, Stroke Rehabilitation, Genetics study (n=565) for replication. The LDL-C and HDL-C summary statistics were pruned (p < 5 × 10 -30 ; r 2 = 0.01) using the 1K Genomes reference panel. Causal effect was modeled utilizing inverse-variance-weighted (IVW), simple median, and Iterative Mendelian Randomization and Pleiotropy (IMRP) models. MR-Egger models assessed residual pleiotropic effects. Results: A total of 459 genetic variants for HDL-C and 464 for LDL-C were included. For HDL-C, the IVW showed a significant inverse causal effect of genetically predicted HDL-C on post-stroke recovery (β = -0.138, 95% CI: -0.012, -0.264, p = 0.032) with replication (β = -0.438, 95% CI: -0.640, -0.236, p < 0.001). Results from simple median and IMRP models were consistent, and MR-Egger intercepts (p = 0.966; p = 0.704) suggested no residual pleiotropy. In contrast, IVW analysis of LDL-C showed no evidence of a causal effect (β: -0.103; 95% CI: -0.224, 0.018; p = 0.097), which replicated (β = -0.066, 95% CI: -0.408, 0.276, p = 0.705). The simple median and IMRP models had consistent results. MR-Egger intercept (β: -0.011; p = 0.014) suggested the presence of residual pleiotropy Conclusion: Our findings indicate that genetically determined HDL-C levels improve post-stroke recovery, suggesting that available circulating HDL-C levels may enhance neuroplasticity independent of the benefits of diet and exercise. In contrast, we found LDL-C levels lack an effect on post-stroke recovery. These results highlight HDL-C as a candidate for further investigation, while supporting current practices around LDL-C management.
Mao et al. (Thu,) reported a other. Genetically predicted HDL-C levels significantly improved post-stroke recovery (β = -0.138, p = 0.032), while LDL-C showed no causal effect (p = 0.097).